Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, Chaigneau L, Berger A, Validire P, Christidis C, Brun-Ly VL, Smyth MJ, Mariette X, Salomon BL, Kroemer G, Rusakiewicz S, Zitvogel L. Ivagnès A, et al. Among authors: mir o. Oncoimmunology. 2017 Oct 11;7(12):e1386826. doi: 10.1080/2162402X.2017.1386826. eCollection 2018. Oncoimmunology. 2017. PMID: 30524877 Free PMC article.
[Taxane-induced skin toxicity and TNF-alpha].
Mir O, Adam J. Mir O, et al. Presse Med. 2008 Feb;37(2 Pt 1):252-3. doi: 10.1016/j.lpm.2007.09.014. Epub 2008 Jan 11. Presse Med. 2008. PMID: 18191367 French. No abstract available.
Individualized Pazopanib Dosing-Letter.
Mir O, Broutin S, Perret A, Le Cesne A, Paci A. Mir O, et al. Clin Cancer Res. 2016 Dec 15;22(24):6298. doi: 10.1158/1078-0432.CCR-16-2104. Clin Cancer Res. 2016. PMID: 27980022 No abstract available.
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
Rusakiewicz S, Perier A, Semeraro M, Pitt JM, Pogge von Strandmann E, Reiners KS, Aspeslagh S, Pipéroglou C, Vély F, Ivagnes A, Jegou S, Halama N, Chaigneau L, Validire P, Christidis C, Perniceni T, Landi B, Berger A, Isambert N, Domont J, Bonvalot S, Terrier P, Adam J, Coindre JM, Emile JF, Poirier-Colame V, Chaba K, Rocha B, Caignard A, Toubert A, Enot D, Koch J, Marabelle A, Lambert M, Caillat-Zucman S, Leyvraz S, Auclair C, Vivier E, Eggermont A, Borg C, Blay JY, Le Cesne A, Mir O, Zitvogel L. Rusakiewicz S, et al. Among authors: mir o. Oncoimmunology. 2016 Apr 25;6(1):e1137418. doi: 10.1080/2162402X.2015.1137418. eCollection 2017. Oncoimmunology. 2016. PMID: 28197361 Free PMC article.
PD-1 inhibition in bone sarcoma and soft-tissue sarcoma.
Mir O, Honoré C, Adam J. Mir O, et al. Lancet Oncol. 2017 Nov;18(11):1430-1431. doi: 10.1016/S1470-2045(17)30685-X. Epub 2017 Oct 4. Lancet Oncol. 2017. PMID: 28988645 No abstract available.
Interventional radiology: Role in the treatment of sarcomas.
de Baere T, Tselikas L, Gravel G, Hakime A, Deschamps F, Honoré C, Mir O, Lecesne A. de Baere T, et al. Among authors: mir o. Eur J Cancer. 2018 May;94:148-155. doi: 10.1016/j.ejca.2018.02.017. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29567631 Review.
338 results